Checchi Capital Advisers’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $304K | Sell |
583
-119
| -17% | -$66.7K | 0.01% | 477 |
|
|
2026
Q1 | $394K | Buy |
702
+130
| +23% | +$83.4K | 0.02% | 400 |
|
|
2025
Q4 | $387K | Sell |
572
-3
| -0.5% | -$2.04K | 0.02% | 381 |
|
|
2025
Q3 | $367K | Sell |
575
-66
| -10% | -$40.1K | 0.02% | 400 |
|
|
2025
Q2 | $344K | Sell |
641
-10
| -2% | -$4.78K | 0.02% | 421 |
|
|
2025
Q1 | $273K | Buy |
651
+16
| +3% | +$6.95K | 0.01% | 479 |
|
|
2024
Q4 | $263K | Sell |
635
-41
| -6% | -$18K | 0.02% | 471 |
|
|
2024
Q3 | $342K | Sell |
676
-8
| -1% | -$3.89K | 0.02% | 419 |
|
|
2024
Q2 | $333K | Buy |
684
+29
| +4% | +$14.6K | 0.02% | 407 |
|
|
2024
Q1 | $354K | Sell |
655
-18
| -3% | -$9.84K | 0.03% | 406 |
|
|
2023
Q4 | $374K | Buy |
673
+72
| +12% | +$33.8K | 0.03% | 374 |
|
|
2023
Q3 | $263K | Sell |
601
-11
| -2% | -$5.49K | 0.02% | 439 |
|
|
2023
Q2 | $307K | Sell |
612
-11
| -2% | -$5.27K | 0.03% | 417 |
|
|
2023
Q1 | $312K | Buy |
623
+46
| +8% | +$22K | 0.03% | 405 |
|
|
2022
Q4 | $235K | Sell |
577
-39
| -6% | -$15.1K | 0.02% | 476 |
|
|
2022
Q3 | $201K | Sell |
616
-31
| -5% | -$11.4K | 0.02% | 514 |
|
|
2022
Q2 | $258K | Sell |
647
-86
| -12% | -$35.1K | 0.02% | 471 |
|
|
2022
Q1 | $401K | Buy |
733
+83
| +13% | +$43.7K | 0.03% | 327 |
|
|
2021
Q4 | $428K | Buy |
650
+13
| +2% | +$8.16K | 0.04% | 297 |
|
|
2021
Q3 | $396K | Buy |
637
+5
| +0.8% | +$3.36K | 0.04% | 295 |
|
|
2021
Q2 | $399K | Sell |
632
-91
| -13% | -$50.2K | 0.04% | 290 |
|
|
2021
Q1 | $354K | Sell |
723
-34
| -4% | -$17K | 0.04% | 309 |
|
|
2020
Q4 | $378K | Sell |
757
-16
| -2% | -$7.16K | 0.04% | 286 |
|
|
2020
Q3 | $304K | Sell |
773
-75
| -9% | -$27.7K | 0.03% | 303 |
|
|
2020
Q2 | $280K | Buy |
+848
| New | +$246K | 0.03% | 321 |
|
|
2019
Q2 | – | Sell |
-1,026
| Closed | -$229K | – | 436 |
|
|
2019
Q1 | $229K | Buy |
+1,026
| New | +$212K | 0.03% | 352 |
|
|
2018
Q4 | – | Sell |
-1,360
| Closed | -$340K | – | 409 |
|
|
2018
Q3 | $340K | Buy |
1,360
+44
| +3% | +$10.7K | 0.04% | 292 |
|
|
2018
Q2 | $287K | Buy |
1,316
+55
| +4% | +$11.3K | 0.04% | 311 |
|
|
2018
Q1 | $241K | Buy |
+1,261
| New | +$233K | 0.03% | 344 |
|
|
2016
Q3 | – | Sell |
-696
| Closed | -$65K | – | 779 |
|
|
2016
Q2 | $65K | Buy |
696
+22
| +3% | +$1.89K | 0.01% | 742 |
|
|
2016
Q1 | $53K | Buy |
+674
| New | +$48.5K | 0.01% | 806 |
|
Other funds holding IDXX
MBI
CGI
Checchi Capital Advisers's IDXX Position: Q2 2026 in Review
Checchi Capital Advisers reduced its Idexx Laboratories (IDXX) stake by 17% in Q2 2026, selling an estimated $66.7K and leaving 583 shares worth $304K. The position accounts for 0.01% of the portfolio, ranked #477.
Checchi Capital Advisers first reported a position in IDXX in Q1 2016 and has held it in 31 quarters since. The position peaked at $428K in Q4 2021. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Checchi Capital Advisers held 583 shares of Idexx Laboratories worth $304K as of Q2 2026.
- Checchi Capital Advisers sold 119 Idexx Laboratories shares in Q2 2026, an estimated $66.7K.
- Idexx Laboratories made up 0.01% of Checchi Capital Advisers's portfolio in Q2 2026, its #477 holding.
- Checchi Capital Advisers first reported a position in Idexx Laboratories in Q1 2016 and has held it in 31 quarters since.
- Checchi Capital Advisers's Idexx Laboratories position peaked at $428K in Q4 2021.
- 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.